Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

Dig Dis Sci. 2021 Jun;66(6):2129-2134. doi: 10.1007/s10620-020-06441-w. Epub 2020 Jul 3.

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
² Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan. nhosoe@z5.keio.jp.
³ Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan.
⁴ Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
⁵ Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan.
⁶ Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

No abstract available

Keywords: Colitis; Enteritis; Gastritis; Immune check point inhibitor; Immune-rerated adverse events (irAE).

Publication types